Dudediligence.

ORIC Pharmaceuticals, Inc

ORICNASDAQ · Pharmaceutical Preparations
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

103.6M

on 2026-06-30, from 67.4M on 2024-03-31 10-Q ↗

25M50M75M100MMar2024JunSepDecMar2025JunSepDecMar2026Jun

Newest

S-3 of 2025-06-11. Not read yet. S-3 ↗

$200.0M

Jefferies, agreement of 2026-02-23. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗

Warrants

4.46M

Warrants of every class as tagged in the XBRL facts on 2026-06-30. 10-Q ↗

Cash

9.5 quarters

$264.8M on 2026-06-30 ÷ $27.9M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised: 4 of its filings are not read yet.